| ID Source | ID |
|---|---|
| PubMed CID | 510978 |
| SCHEMBL ID | 16781783 |
| MeSH ID | M0078097 |
| Synonym |
|---|
| 2-azido-adenosine |
| nsc 36905 |
| adenosine, 2-azido- |
| (2r,3r,4s,5r)-2-(6-amino-2-azido-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
| (4s,2r,3r,5r)-2-[6-amino-2-(diazoazamvinyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
| 59587-07-4 |
| 2-azidoadenosine |
| (2r,3r,4s,5r)-2-(6-amino-2-azidopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
| 2-(6-amino-2-azidopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
| 2-azido adenosine |
| DTXSID60208247 |
| SCHEMBL16781783 |
| AKOS030240741 |
| nsc 36905; |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||